National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

montelukast (mon-teh-LOO-kast)

 The active ingredient in a drug used to treat symptoms of asthma, such as trouble breathing, tight chest, wheezing, coughing, and runny nose. Montelukast blocks the action of a substance that causes airways in the lungs to narrow and causes other symptoms of asthma. It is a type of leukotriene receptor antagonist and a type of antiasthmatic agent.



Previous Definitions:monoclonal gammopathy of undetermined significance, monoclonal protein, monocyte, monomer, Montanide ISA-51
Next Definitions:montelukast sodium, MOPP, MOPP regimen, MORAb-009, morbidity

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov